HEALTH

Wills Eye Institute: Incidence linking aspirin to macular degeneration too low to stop aspirin therapy

BY Michael Johnsen

PHILADELPHIA — "Talk to your cardiologist." That’s the advice offered Friday by Wills Eye Institute, a hospital specializing in eye care,  following a JAMA article linking aspirin therapy to macular degeneration. 

"There’s no need for patients to experience undue worry," noted Julia Haller, Wills Eye Institute ophthalmologist-in-chief. "The overall risk for developing serious eye disease on aspirin in the study was low — 3.7% after 15 years," she said. "It is very important to discuss your risk factors before stopping or reducing any aspirin therapy since aspirin can often stave off life threatening heart attacks and strokes."

The hospital released its statement referencing increased confusion and anxiety in the general public about whether aspirin can harm their vision and what to do if they need the heart-protective therapy.


Find us on Facebook for even more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Oceans Omega launches omega-3 enhanced water

BY Michael Johnsen

PARAMUS, N.J. — Oceans Omega on Monday launched Omega Infusion, an omega-3 EPA/DHA enhanced water product with initial placement within Giant Food.

"Delivering heart healthy omega-3 fatty acids in enhanced water is something we’ve been developing for years," stated Volker Berl, chief technology officer Oceans Omega. "Our proprietary delivery system is transforming the beverage industry by including ingredients like Omega-3 EPA/DHA."

Each bottle of Omega Infusion water delivers 80mg of essential omega-3s, 200% of the recommended daily value of vitamin C and 80% of four B vitamins. Omega Infusion will retail for a suggested $1.99 and include flavors berry, citrus, fruit punch and orange. 


Find us on Facebook for even more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Forbes: Retail pharmacy flush with flu business

BY Michael Johnsen

NEW YORK — This year’s virulent flu season driven by a predominant H3N2 bug has people hitting their drug stores in droves in search of symptomatic relief, suggested an article published online by Forbes Monday

And retail pharmacy operators like Walgreens have adjusted their messaging to match that heightened demand for cough and cold products. The Forbes article featured a Walgreens advertisement that listed all the products a flu sufferer might need — tissues, lozenges, medicine, sanitizer and lip balm.

The article also acknowledged retail pharmacy as a destination for flu shots. Walgreens, in particular, inoculated as many patients from the flu in January as they typically do in October — the peak of the flu-shot giving season — the retailer told the business journal. 


Find us on Facebook for even more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?